[Federal Register Volume 69, Number 80 (Monday, April 26, 2004)]
[Notices]
[Page 22566]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-9328]



[[Page 22566]]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Withdrawal of 
Application

    By notice dated December 24, 2003, and published in the Federal 
Register on January 27, 2004 (68 FR 39437), Novartis Pharmaceuticals 
Corporation, Attn: Security Department, Building 103, Room 335, 59 
Route 10, East Hanover, New Jersey 07936, made application by renewal 
to the Drug Enforcement Administration to be registered as a bulk 
manufacturer of Methylphenidate (1724), a basic class of controlled 
substance in Schedule II.
    The firm planned to produce bulk product and finished dosage units 
for distribution to its customers.
    By letter dated March 11, 2004, the firm stated that it is no 
longer engaged in the bulk manufacture of this controlled substance. 
The renewal application for Novartis Pharmaceuticals Corporation is 
hereby withdrawn.

    Dated: April 1, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 04-9328 Filed 4-23-04; 8:45 am]
BILLING CODE 4410-09-M